Apotheek Plaza
ActiveSummary
Apotheek Plaza has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€200,609) and a net result of -€47,929. Equity has been shrinking by about 38% per year since 2018. Its solvency ranks better than 9% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.5% (low).
Overview
Official details
Source: KBO- Status
- Active since 22-05-2014 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.231.564.875 8800 Roeselare, since 19-06-2014
- Financial year end
- 31 December
- Peppol
- Reachable since 20-11-2025
Board and ownership
- GEZONDHEIDSGROEP GROEN HARTDirector · permanent representative Inge De Keyzer
- Apotheek Mieke BouttelisierDirector
- Apotheek Meense & Delta99%· score 962025 annual accounts of Apotheek Meense & Delta
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.5%
- Gross margin
- €108,672
- ▲ 22.8%
- Turnover
- ≈ €510,000
- estimated
- Loss
- €47,929
- ▼ 38.6%
- Equity
- -€200,609
- ▼ 31.4%
- Total assets
- €871,423
- ▼ 6.1%
- Employees on 31-12-2025
- 1
- =
- Negative equity on 31-12-2025
Score breakdownraises riskCapped at 59: negative equityNegative equity -€200,609Loss of €47,929, the second in a row (financial year 2025)Sector: Retail trade (NACE 47)lowers riskSize: 0.8 FTE, total assets €871,423Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 13% of them on solvency, 68% on liquidity, 23% on profitability and 15% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 9 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: Negative equitydebts exceed assets in financial year 2025 -€200,609 View
- Risk: 4 loss-making years in a rowloss in financial year 2025 -€47,929 View
- Caution: Less equity than 95% of companies in retail tradesector median €236,771 · 12,767 companies -€200,609 View
- New directorlatest change 02-10-2026 · 2 in office 1 joined View
Recent changes
- · Gazette deed Appointment: GEZONDHEIDSGROEP GROEN HART (director)Permanent representatives: Anne-Sofie Beckx, Inge De Keyzer and Mieke Bouttelisier
- · Gazette deed Company renamed from DECKERS-RAPPÉ to Apotheek PlazaResignation: Apotheek Mieke Bouttelisier (manager and director) · Reappointment: Apotheek Mieke Bouttelisier (director) · Permanent representative: Mieke BOUTTELISIER
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as Apotheek Plaza: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €656,000 and €1.1m, founded between 2010 and 2017.
| Company | Total assets | Gross margin |
|---|---|---|
| Apotheek Plaza Roeselare | €0.9m | €0.1m |
| APOTHEEK RAES Oostende | €0.7m | €0.1m |
| APOTHEEK MEENSEPOORT Kortrijk | €0.9m | €0.1m |
| Apotheek Sigrid Saelens Poperinge | €1.1m | €0.1m |
| Stéphanie GEVAERT Waregem | €0.8m | €0.1m |
| Apotheek Fevery Blankenberge | €1.1m | €0.1m |
| APOTHEEK DEBRUYNE ELLEN Knokke-Heist | €0.7m | €0.1m |
Key facts about Apotheek Plaza
- What is the company number of Apotheek Plaza?
- The company number of Apotheek Plaza is 0553.778.245. The VAT number is the same number with BE in front: BE 0553.778.245.
- Where is Apotheek Plaza based?
- The registered office is at Koestraat 179/1, 8800 Roeselare.Company details
- What does Apotheek Plaza do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Apotheek Plaza?
- The legal form of Apotheek Plaza is Private limited company (BV).
- When was Apotheek Plaza founded?
- Apotheek Plaza was founded on 22-05-2014.
- Is Apotheek Plaza still active?
- Yes, Apotheek Plaza is an active enterprise in the KBO register.
- How many employees does Apotheek Plaza have?
- Apotheek Plaza had an average of 0.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Apotheek Plaza?
- The turnover in financial year 2025 is ≈ €510,000. This figure is estimated from the gross margin of €108,672 and 51 comparable companies (NACE 477). It probably lies between €340,000 and €980,000.
- Is Apotheek Plaza profitable?
- In financial year 2025, Apotheek Plaza made a loss of €47,929.
- Where can I find the annual accounts of Apotheek Plaza?
- Apotheek Plaza filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Apotheek Plaza due?
- Apotheek Plaza must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.